☆ 4.7 Editorial Material

Inclusion of Sexual Orientation and Gender Identity in Clinical Trials Is Necessary for Health Equity

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Sexual Orientation and Gender Identity Data Collection in Oncology Practice: Findings of an ASCO Survey

Charles S. Kamen et al.

Summary: The lack of sexual orientation and gender identity (SOGI) data collection in oncology practices hinders the assessment of experiences and health outcomes of sexual and gender minority (SGM) cancer patients. This study identifies barriers to SOGI data collection in oncology, finding that leadership support, dedicated resources, and individual attitudes are critical in promoting meaningful data collection and use in clinical practice.

JCO ONCOLOGY PRACTICE (2022)

添加到收藏夹

Article Oncology

Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States

Sarah S. Jackson et al.

Summary: Transgender patients are more likely to be diagnosed with cancer at advanced stages, less likely to receive treatment, and have poorer survival rates for many cancer types compared to cisgender patients. The small sample size in this study limited the ability to detect statistically significant differences for some cancer sites. There is a need for more research focused on cancer in transgender populations.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Acceptability and Feasibility of Collecting Sexual Orientation and Expanded Gender Identity Data in Urology and Oncology Clinics

B. R. Simon Rosser et al.

Summary: The study found that collecting sexual orientation and gender identity data in oncology and urology clinical settings is acceptable and feasible, with many patients finding the questions easy to understand and answer.

LGBT HEALTH (2021)

添加到收藏夹

Letter Oncology